Bavarian Nordic A/S (WBO:BAVA)
€ 23.81 -0.33 (-1.38%) Market Cap: 1.85 Bil Enterprise Value: 1.56 Bil PE Ratio: 13.77 PB Ratio: 1.36 GF Score: 48/100

Bavarian Nordic A/S to acquire BioSolutions Inc. Transcript

Feb 15, 2023 / 01:00PM GMT
Release Date Price: €30.14 (-0.63%)
Operator

Good day, and thank you for standing by. Welcome to the Bavarian Nordic conference call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Rolf Sass. Please go ahead.

Rolf Sass SÃ;rensen;S;VP of IR;Communications
Bavarian Nordic A

¸ - /-&

Thank you, operator, and welcome to everyone.

Today's call is about the strategic acquisition about some travel vaccines. And on today's call, we have, as usual, members of the executive management team, President and CEO, Paul Chaplin, and effective member, CFO, Henrik Juuel. And my name is Rolf Sørensen, Vice President, Investor Relations.

Before we start the presentation, I just will run through the disclaimer. This presentation includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside our control that could cause actual results to differ materially from the results

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot